Control of asthma at the 3rd-line pulmonary diseases clinics (3rd line pdc) according GINA (global initiative for asthma) parameters

B. Gemicioglu, F. Yildiz, M. Polatli, S. Atis, A. B. Dursun, F. Oner Erkekol, H. Turker, B. Ocakli, G. Camsari, A. Gur, S. Kepil Ozdemir, O. Aydin, O. Abadoglu, A. Cimrin, M. L. Erkan, H. Günen, O. Goksel (Istanbul, Kocaeli, Aydin, Mersin, Ankara, Sivas, Izmir, Samsun, Malatya, Turkey)

Source: Annual Congress 2009 - Aspects of clinical asthma
Session: Aspects of clinical asthma
Session type: Thematic Poster Session
Number: 1970
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Gemicioglu, F. Yildiz, M. Polatli, S. Atis, A. B. Dursun, F. Oner Erkekol, H. Turker, B. Ocakli, G. Camsari, A. Gur, S. Kepil Ozdemir, O. Aydin, O. Abadoglu, A. Cimrin, M. L. Erkan, H. Günen, O. Goksel (Istanbul, Kocaeli, Aydin, Mersin, Ankara, Sivas, Izmir, Samsun, Malatya, Turkey). Control of asthma at the 3rd-line pulmonary diseases clinics (3rd line pdc) according GINA (global initiative for asthma) parameters. Eur Respir J 2009; 34: Suppl. 53, 1970

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
If the global initiative for asthma (GINA) reflected on the asthma therapy in Croatia?
Source: Eur Respir J 2001; 18: Suppl. 33, 46s
Year: 2001

Can asthma control test (ACT) replace a global assessment of asthma control according to GINA guidelines?
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011


Global strategy for asthma management and prevention: GINA executive summary
Source: Eur Respir J 2008; 31: 143-178
Year: 2008



Reslizumab (RES) in asthma patients (pts) with severe eosinophilic asthma stratified by GINA asthma steps 4 and 5: Analysis of two phase 3, placebo (PBO)-controlled trials
Source: International Congress 2016 – Asthma management
Year: 2016


Global asthma physician & patient (GAPP) survey: differences between treatment practice and GINA guideline recommendations in Europe – adult findings
Source: Annual Congress 2006 - New developments in the management of asthma
Year: 2006


Monitoring COPD patients according to the GOLD 2017 document: systemic and bronchial inflammation.
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020


Disease progression and changes in risk groups' classification over a period of one year in the GPs based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care
Year: 2014


COPD severity analysis according to current evaluation criteria – National survey
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015


Adherence to national (UK) respiratory guidelines in general practice
Source: Annual Congress 2007 - Delivering respiratory care: the challenges for primary care
Year: 2007



Health locus of control in pulmonary rehabilitation (PR) of severe COPD patients
Source: International Congress 2016 – Latest insights into pulmonary rehabilitation
Year: 2016


The influence of bronchial asthma as a comorbidity of COPD on the COPD assessment test (CAT)
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014


Clinic-economical analysis of the six-part asthma management program (GINA) efficiency in polyclinic
Source: Eur Respir J 2007; 30: Suppl. 51, 193s
Year: 2007

Personalizing asthma care base on Asthma Control Test (ACT) correlation with treatment of asthma comorbidities in a Malaysian cohort
Source: Virtual Congress 2020 – Clinical parameters in severe asthma
Year: 2020


Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014


New GOLD recommendations in a seven years follow up - changes in symptoms and risk categories
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013

Global asthma physician & patient (GAPP) survey: satisfaction with current asthma medications in Europe – adult findings
Source: Annual Congress 2006 - New developments in the management of asthma
Year: 2006


Comparing Global Initiative for Asthma (GINA) criteria with the Childhood Asthma Control Test (C-ACT) and Asthma Control Test (ACT)
Source: Eur Respir J 2011; 38: 561-566
Year: 2011



Asthma control test: Cut off values of control according to GINA guideline and its ability to predict exacerbations and treatment decisions
Source: Annual Congress 2011 - Clinical parameters in airway diseases
Year: 2011

Pattern of asthma control and inhaled corticosteroid (ICS) use in an Australian asthma population
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013


Global asthma physician & patient (GAPP) survey: differences between treatment practice and GINA guideline recommendations in Europe – paediatric findings
Source: Eur Respir J 2006; 28: Suppl. 50, 480s
Year: 2006